However, two separate studies in populations with IBD, who were tested prior to initiation of anti-TNFα, showed indeterminate results in 19.5% and 22% of the population [13,14], where authors found corticosteroid use and hospitalization were risk factors associated with an indeterminate result. The gene discussed is TNF; the disease is inflammatory bowel disease.